Flu vaccine showdown: which type works best?
NCT ID NCT05479370
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compared three different flu vaccines: one made using eggs, one using cells, and one using a lab-made protein. The goal was to see which vaccine triggers the strongest antibody response, especially against a tricky flu strain called H3N2. 366 adults who hadn't had a flu shot in the last 6 months took part, and their immune responses were tracked over nearly a year.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLUENZA VACCINATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
National Centre for Infectious Diseases (NCID)
Singapore, Singapore, 308442, Singapore
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Everyday drugs might tame COVID: 3,000-Patient trial launched
- Daycare flu shots could boost child vaccination rates
- New combo vaccine targets flu, RSV, and more in early trial
- Flu shot linked to fewer deaths after fractures in seniors
- Study probes whether measuring intentions boosts flu shot uptake
- School staff trained to fight flu: will it work?